Truffle Capital

Wyden is a global leader in institutional digital asset trading technology, providing comprehensive infrastructure solutions for financial institutions. The Wyden platform encompasses the entire trade lifecycle, from pre-trade risk assessments to order generation and automated settlement. It supports seamless integration with custody, core banking, and portfolio management systems, facilitating a smooth transition between digital and traditional assets. Engineered by a team of experts in both trading systems and crypto assets, Wyden aims to meet the highest standards of institutional needs. The company operates offices in Zurich, New York, and Singapore.

DgPays is a financial technology company that specializes in providing comprehensive payment solutions tailored for banks, e-money institutions, telecom operators, and transportation operators. The company's platform includes a range of services such as online and mobile payment systems, mobile wallets, prepaid cards, and bill payment solutions. Additionally, DgPays offers tools for managing loyalty programs and payment gateway infrastructure. Their solutions also encompass essential banking services, including compliance, fraud management, and authentication, ensuring secure and efficient financial transactions. By integrating these diverse services, DgPays aims to facilitate seamless and convenient financial experiences for its clients and their customers.

Obat provides invoicing and payment software designed for contractors and independent contractors in the construction industry. The platform offers features for estimation, project management, site monitoring, and invoice generation specifically for building craftsmen. By continually evolving based on feedback from customers and partners, Obat aims to enhance operational efficiency for small and medium enterprises, allowing them to concentrate on their core business activities and improve their overall value proposition.

Levenue is a European revenue-based financing platform aimed at helping founders unlock the value of their recurring revenues. The company has developed a marketplace that connects institutional investors with businesses seeking growth capital. By transforming recurring revenues into upfront cash, Levenue enables companies to obtain funding quickly without diluting shareholder equity or relying on significant consumer discounts. The platform not only facilitates funding requests but also offers insights into business metrics, allowing clients to finance their growth while maintaining control over their operations. Levenue's mission is to empower founders to focus on their core business objectives.

MoneyTrack is a global, decentralized blockchain platform designed to facilitate directed money exchanges among financers, beneficiaries, and partners. The platform allows users to establish directed money programs with customizable features, pricing, and commission structures. This flexibility enables end-users to access markets more easily while reducing their operating costs. By leveraging blockchain technology, MoneyTrack aims to streamline financial transactions and improve the efficiency of money management across various stakeholders.

Obat provides invoicing and payment software designed for contractors and independent contractors in the construction industry. The platform offers features for estimation, project management, site monitoring, and invoice generation specifically for building craftsmen. By continually evolving based on feedback from customers and partners, Obat aims to enhance operational efficiency for small and medium enterprises, allowing them to concentrate on their core business activities and improve their overall value proposition.

Abivax is a clinical-stage biotechnology company based in France that develops therapeutics aimed at harnessing the body's natural immune response to treat autoimmune diseases, viral infections, and cancer. The company is currently evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Abivax focuses on addressing significant unmet medical needs in chronic inflammatory diseases, particularly inflammatory bowel diseases, which include ulcerative colitis and Crohn's disease. Through its innovative drug development platforms, Abivax aims to provide novel and effective treatment options for patients suffering from these conditions.

Bridge is a banking data and payment system. They offer banking aggregation, payment initiation, open data, electronic invoices, debt collection, e-commerce sites and digital and physical commerce, factoring, kitty service, wallets, single and multiple payments, finance and insurance, credit, risk, and fraud experts.

Cachet OÜ, established in 2018 and headquartered in Tallinn, Estonia, operates an innovative online insurance brokerage platform focused on the mobility sector, particularly for ride-hailing drivers. The company offers a variety of insurance products, including traffic and casco insurance, as well as fleet insurance. Cachet serves as a data intermediary between gig economy platforms and insurance providers by aggregating and enriching data on service provision across multiple platforms. This data-driven approach enables insurance companies to deliver personalized coverage options tailored to individual service providers based on their actual working hours, thereby enhancing pricing, predictability, and risk management within the gig and sharing economy.

RollingFunds, founded in 2018 and headquartered in Paris, France, specializes in providing short-term financing solutions to small and medium-sized enterprises (SMEs). The company has developed a credit management platform that leverages machine learning-based instant scoring algorithms to automate the loan granting and management processes. This technology simplifies access to cash financing for businesses and enhances financial interactions within B2B relationships. By streamlining the financing process, RollingFunds enables SMEs to obtain tailored financing solutions that meet their specific needs, thereby supporting their growth and operational efficiency.

Cake App mission is to become the leading software technology provider that analyzes financial data to help people better understand, control and improve their finances, supported by a business model that shares our revenue with users.

IPaidThat is a financial technology platform that streamlines accounting for startups and small to medium-sized enterprises (SMEs). The platform utilizes artificial intelligence to automatically import invoices and expense reports, ensuring that all financial documents are accurately collected and entered. By comparing these documents with bank transactions, IPaidThat helps businesses minimize the risk of overlooking any financial obligations. This automation simplifies the accounting process, allowing users to focus on other aspects of their operations while maintaining accurate financial records.

Monisnap SAS is a French fintech company that operates a digital instant money transfer platform and mobile application. Founded in 2017 and based in Paris, Monisnap specializes in remittance services, enabling users to send money abroad quickly and easily. The platform facilitates money transfers from Europe to various destinations worldwide, catering to individuals who need to send funds to family, friends, and business partners.

Zaion is a European company specializing in customer relationship solutions enhanced by artificial intelligence. The company has developed an AI-powered conversational platform that automates customer interactions through intelligent chatbot software. This platform facilitates voice customer relationship processing by utilizing remote advisors to handle inquiries, thereby enabling businesses to create personalized connections with their clients. By optimizing customer relations, Zaion's technology aims to improve customer satisfaction while reducing operational costs for businesses.

Acasi SAS is a company based in Paris, France, that specializes in developing accounting management software tailored for freelancers across various sectors, including architecture, law, consultancy, and coaching. Founded in 2017, Acasi's software streamlines financial management by automating tasks such as online quotations, invoicing, VAT management, and expense tracking. Additionally, it provides real-time cash monitoring and personalized financial coaching, helping users alleviate the administrative burdens associated with their accounting practices. Through its innovative solutions, Acasi aims to enhance the efficiency and effectiveness of financial management for freelancers.

MoneyTrack is a global, decentralized blockchain platform designed to facilitate directed money exchanges among financers, beneficiaries, and partners. The platform allows users to establish directed money programs with customizable features, pricing, and commission structures. This flexibility enables end-users to access markets more easily while reducing their operating costs. By leveraging blockchain technology, MoneyTrack aims to streamline financial transactions and improve the efficiency of money management across various stakeholders.

Smile & Pay provides electronic payment solutions tailored for small and medium-sized merchants, allowing them to accept payments via smartphones without incurring fixed fees. The company offers products such as PocketSmile, a compact mobile terminal that accommodates all major credit cards, and MaxiSmile, which includes a printer and mobile GPRS capabilities. In addition to facilitating transactions, Smile & Pay's software enables users to manage and track their accounts and receipts in real time through computers or mobile devices. This innovative approach allows professionals and merchants to conduct business efficiently and securely, enhancing their ability to serve customers in various settings.

Particeep is a fintech company that specializes in providing banks, insurers, asset managers, and their distributors with no-code solutions for the distribution of financial products and services. The company’s platform enables clients to establish digital subscription channels quickly—typically within a month—without the need for IT development. Additionally, Particeep offers a REST API comprising various micro-services related to banking, insurance, and investment, facilitating the automation of data sharing with existing information systems and third-party applications. This makes it easier for financial institutions to manage and distribute their offerings effectively.

WeGroup is a Belgian InsurTech company that enhances the relationship between insurance brokers and their digital customers. Through its 24/7 virtual assistant, Louise, which leverages data analytics and robotic automation, WeGroup improves customer service by providing faster and more personalized support. The company's innovative solutions have garnered over 15 international awards in the fields of insurance and technology. By focusing on customer needs and risk prediction, WeGroup helps insurance providers increase sales and improve portfolio quality while simultaneously lowering operational costs. Their clientele includes insurance companies, intermediaries, and banks across Europe, reflecting their commitment to transforming the insurance landscape.

Monisnap SAS is a French fintech company that operates a digital instant money transfer platform and mobile application. Founded in 2017 and based in Paris, Monisnap specializes in remittance services, enabling users to send money abroad quickly and easily. The platform facilitates money transfers from Europe to various destinations worldwide, catering to individuals who need to send funds to family, friends, and business partners.

RollingFunds, founded in 2018 and headquartered in Paris, France, specializes in providing short-term financing solutions to small and medium-sized enterprises (SMEs). The company has developed a credit management platform that leverages machine learning-based instant scoring algorithms to automate the loan granting and management processes. This technology simplifies access to cash financing for businesses and enhances financial interactions within B2B relationships. By streamlining the financing process, RollingFunds enables SMEs to obtain tailored financing solutions that meet their specific needs, thereby supporting their growth and operational efficiency.

IPaidThat is a financial technology platform that streamlines accounting for startups and small to medium-sized enterprises (SMEs). The platform utilizes artificial intelligence to automatically import invoices and expense reports, ensuring that all financial documents are accurately collected and entered. By comparing these documents with bank transactions, IPaidThat helps businesses minimize the risk of overlooking any financial obligations. This automation simplifies the accounting process, allowing users to focus on other aspects of their operations while maintaining accurate financial records.

Smile & Pay provides electronic payment solutions tailored for small and medium-sized merchants, allowing them to accept payments via smartphones without incurring fixed fees. The company offers products such as PocketSmile, a compact mobile terminal that accommodates all major credit cards, and MaxiSmile, which includes a printer and mobile GPRS capabilities. In addition to facilitating transactions, Smile & Pay's software enables users to manage and track their accounts and receipts in real time through computers or mobile devices. This innovative approach allows professionals and merchants to conduct business efficiently and securely, enhancing their ability to serve customers in various settings.

MoneyTrack is a global, decentralized blockchain platform designed to facilitate directed money exchanges among financers, beneficiaries, and partners. The platform allows users to establish directed money programs with customizable features, pricing, and commission structures. This flexibility enables end-users to access markets more easily while reducing their operating costs. By leveraging blockchain technology, MoneyTrack aims to streamline financial transactions and improve the efficiency of money management across various stakeholders.

Géocorail développe et commercialise un produit innovant faisant travailler la mer à la protection du littoral : le Géocorail®. Ce procédé électrochimique breveté innovant consiste à créer une roche artificielle permettant de protéger les ouvrages marins et de lutter contre l’érosion du littoral.

Theraclion is a French company founded in 2004 that specializes in high-tech medical equipment utilizing high-intensity focused ultrasound (HIFU) technology. The company has developed innovative echotherapy solutions that integrate HIFU therapy with ultrasound imaging to non-invasively target and treat benign tumors and varicose veins. Its flagship product, Echopulse®, is designed for the non-invasive treatment of breast fibroadenomas and benign thyroid nodules, while the SONOVEIN® system specifically addresses varicose veins in the lower limbs. Theraclion's focus on ultrasound for therapeutic applications positions it as a pioneer in this field, offering advanced solutions for patients requiring non-invasive treatment options.

Myopowers Medical Technologies is a French medical device company that develops innovative technologies to provide muscle assistance to patients with high unmet medical needs. The technology can be applied to a number of indications in the GI, cardiology or urology area. The company focus is the development of ARTUS, a new and unique implantable device for the treatment of stress urinary incontinence. Stress urinary incontinence is a condition that affects millions of people around the world. Unfortunately, currently available products are old with significant limitations such as tissue erosion, infection or mechanical failure leading frequent re-operation. ARTUS is made of smooth and flat silicon cuff placed around the urethra. It is individually actionable and adjustable with a remote control allowing patients easy voiding and the surgeon monitoring and adjusting the cuff. This device is the first artificial urinary system specifically designed to include the treatment of female patients who account for a vast majority of the urinary incontinence market.

Actility S.A., founded in 2010 and headquartered in Lannion, France, is a leader in Low Power Wide Area Networks (LPWAN) and specializes in machine-to-machine communication solutions. The company's flagship platform, ThingPark, provides a carrier-grade Internet of Things (IoT) infrastructure that supports scalable deployments of mission-critical applications. ThingPark facilitates the connection between sensors and cloud applications, accommodating a wide range of use cases from global networks to secure enterprise solutions. Actility features a growing ecosystem of partners and offers middleware that enables seamless integration of data from various sensors. Additionally, the company operates a B2B e-commerce marketplace that connects businesses with vetted IoT device, connectivity, and application providers. As a founding member of the LoRa Alliance™, Actility is committed to advancing IoT technologies and fostering collaboration within the industry.

Altimmune, Inc. is a clinical stage biopharmaceutical company based in Gaithersburg, Maryland, specializing in the development of innovative treatments for liver disease, obesity, and vaccines. The company’s pipeline includes HepTcell, an immunotherapeutic candidate for chronic hepatitis B, which has successfully completed Phase I clinical trials. Altimmune also develops NasoShield, an intranasal anthrax vaccine, and NasoVAX, a recombinant intranasal vaccine. Additionally, the company is advancing AdCOVID, a single-dose intranasal vaccine for COVID-19. In the preclinical stage, Altimmune is working on ALT-801, a peptide-based dual GLP-1/glucagon receptor agonist for non-alcoholic steatohepatitis, as well as ALT-702, a tumor immunostimulant aimed at cancer treatment. The company employs proprietary technology for non-invasive intranasal delivery of its products and collaborates with institutions such as the University of Alabama at Birmingham to further its research initiatives.

SP3H specializes in innovative smart optical sensor technology aimed at reducing pollutant emissions in industrial settings. The company develops advanced sensors that utilize near-infrared systems to analyze the molecular structure of liquid fuels in vehicles. By adjusting settings based on real-time fuel quality data, SP3H's technology enhances combustion efficiencies, leading to lower carbon dioxide emissions and reduced fuel consumption. This focus on environmental sustainability aligns with the pressing energy challenges of the 21st century, positioning SP3H as a key player in the development of solutions that support cleaner industrial practices.

CoolGames is a developer of cloud-based interactive and casual games, focusing on delivering high-quality gaming experiences to players worldwide. Since its establishment in 2009, the company has utilized 100% HTML5 technology to publish a diverse portfolio of games, including well-known intellectual properties such as Angry Birds, Tetris, Snake, and Battleship. By offering a click-and-play platform, CoolGames allows users to access and enjoy its games on various devices, including smartphones, personal computers, and tablets, without the need for downloads. This approach ensures that players can engage with their favorite games anytime and anywhere, reflecting the company's commitment to providing accessible and enjoyable gaming experiences.

MoMac is a global technology company specializing in customer engagement solutions for leading Communication Service Providers (CSPs). It operates the mvolve platform, which integrates internal data systems, service offerings, content, and on-device user interfaces to enhance CSP-customer interactions. This integration enables CSPs to reduce costs, increase revenue, and accelerate solution deployment. MoMac serves prominent CSP clients such as Orange Group, Vodafone, Telefónica, Three, KPN, and T-Mobile across 27 countries, with offices in the US, UK, Netherlands, and France.

Carbios is a company focused on developing enzymatic bioprocesses for recycling plastic waste and creating biodegradable plastics. It specializes in breaking down polyethylene terephthalate (PET), a widely used plastic in bottles and containers, through enzymatic methods. This innovative approach not only aims to facilitate the recycling of plastic materials but also promotes the production of bio-sourced polymers. Carbios is committed to addressing the environmental challenges posed by plastic pollution by contributing to a circular economy, enabling infinite biorecycling of plastic waste, and offering a new generation of fully biodegradable plastics with a controlled lifespan. Their work emphasizes sustainability and the potential for reducing the ecological impact of traditional plastic usage.

SP3H specializes in innovative smart optical sensor technology aimed at reducing pollutant emissions in industrial settings. The company develops advanced sensors that utilize near-infrared systems to analyze the molecular structure of liquid fuels in vehicles. By adjusting settings based on real-time fuel quality data, SP3H's technology enhances combustion efficiencies, leading to lower carbon dioxide emissions and reduced fuel consumption. This focus on environmental sustainability aligns with the pressing energy challenges of the 21st century, positioning SP3H as a key player in the development of solutions that support cleaner industrial practices.

Pharnext SA is a clinical-stage biopharmaceutical company based in Issy-Les-Moulineaux, France, specializing in the development of therapies for orphan and common neurodegenerative diseases. Founded in 2007 by prominent scientists and entrepreneurs, Pharnext employs a novel approach called PLEOTHERAPY, which uses network pharmacology and extensive genomic data to identify synergistic drug combinations from existing approved medications. Its leading products include SYNGILITY, which has successfully completed Phase III trials for Charcot-Marie-Tooth disease type 1A, and PXT864, which has shown promise in Phase II trials for Alzheimer’s disease, as well as in the treatment of Parkinson’s disease and amyotrophic lateral sclerosis. Pharnext also collaborates with the University Hospital Institute Mediterranee Infection to explore repurposed drugs for potential COVID-19 treatment. The company's innovative drug development strategy aims to provide effective and safe therapies while securing intellectual property through numerous granted patents.

CoolGames is a developer of cloud-based interactive and casual games, focusing on delivering high-quality gaming experiences to players worldwide. Since its establishment in 2009, the company has utilized 100% HTML5 technology to publish a diverse portfolio of games, including well-known intellectual properties such as Angry Birds, Tetris, Snake, and Battleship. By offering a click-and-play platform, CoolGames allows users to access and enjoy its games on various devices, including smartphones, personal computers, and tablets, without the need for downloads. This approach ensures that players can engage with their favorite games anytime and anywhere, reflecting the company's commitment to providing accessible and enjoyable gaming experiences.

Biokinesis is a biotechnology company developing new treatments for cancer by targeting a specific kinesin found in several cancers.

Pharnext SA is a clinical-stage biopharmaceutical company based in Issy-Les-Moulineaux, France, specializing in the development of therapies for orphan and common neurodegenerative diseases. Founded in 2007 by prominent scientists and entrepreneurs, Pharnext employs a novel approach called PLEOTHERAPY, which uses network pharmacology and extensive genomic data to identify synergistic drug combinations from existing approved medications. Its leading products include SYNGILITY, which has successfully completed Phase III trials for Charcot-Marie-Tooth disease type 1A, and PXT864, which has shown promise in Phase II trials for Alzheimer’s disease, as well as in the treatment of Parkinson’s disease and amyotrophic lateral sclerosis. Pharnext also collaborates with the University Hospital Institute Mediterranee Infection to explore repurposed drugs for potential COVID-19 treatment. The company's innovative drug development strategy aims to provide effective and safe therapies while securing intellectual property through numerous granted patents.

Myopowers Medical Technologies is a French medical device company that develops innovative technologies to provide muscle assistance to patients with high unmet medical needs. The technology can be applied to a number of indications in the GI, cardiology or urology area. The company focus is the development of ARTUS, a new and unique implantable device for the treatment of stress urinary incontinence. Stress urinary incontinence is a condition that affects millions of people around the world. Unfortunately, currently available products are old with significant limitations such as tissue erosion, infection or mechanical failure leading frequent re-operation. ARTUS is made of smooth and flat silicon cuff placed around the urethra. It is individually actionable and adjustable with a remote control allowing patients easy voiding and the surgeon monitoring and adjusting the cuff. This device is the first artificial urinary system specifically designed to include the treatment of female patients who account for a vast majority of the urinary incontinence market.

Utel SAS, based in Paris, France, specializes in creating mobile applications for social networking and collaborative services. The company's flagship platform, Allokang, enables users to buy or sell skills, talents, and expertise across various fields, including legal, financial, academic support, IT, mental health, personal development, entertainment, and astrology. Additionally, Utel offers Backstage SMS, which provides tools for interactive engagement such as game initiation and voting, alongside a web interface that allows animators to manage listener messages and multimedia submissions. This functionality also enables monetization of community page traffic, allowing users to participate in paid activities. Established in 2000, Utel continues to innovate in the mobile application space.

Actility S.A., founded in 2010 and headquartered in Lannion, France, is a leader in Low Power Wide Area Networks (LPWAN) and specializes in machine-to-machine communication solutions. The company's flagship platform, ThingPark, provides a carrier-grade Internet of Things (IoT) infrastructure that supports scalable deployments of mission-critical applications. ThingPark facilitates the connection between sensors and cloud applications, accommodating a wide range of use cases from global networks to secure enterprise solutions. Actility features a growing ecosystem of partners and offers middleware that enables seamless integration of data from various sensors. Additionally, the company operates a B2B e-commerce marketplace that connects businesses with vetted IoT device, connectivity, and application providers. As a founding member of the LoRa Alliance™, Actility is committed to advancing IoT technologies and fostering collaboration within the industry.

Pharnext SA is a clinical-stage biopharmaceutical company based in Issy-Les-Moulineaux, France, specializing in the development of therapies for orphan and common neurodegenerative diseases. Founded in 2007 by prominent scientists and entrepreneurs, Pharnext employs a novel approach called PLEOTHERAPY, which uses network pharmacology and extensive genomic data to identify synergistic drug combinations from existing approved medications. Its leading products include SYNGILITY, which has successfully completed Phase III trials for Charcot-Marie-Tooth disease type 1A, and PXT864, which has shown promise in Phase II trials for Alzheimer’s disease, as well as in the treatment of Parkinson’s disease and amyotrophic lateral sclerosis. Pharnext also collaborates with the University Hospital Institute Mediterranee Infection to explore repurposed drugs for potential COVID-19 treatment. The company's innovative drug development strategy aims to provide effective and safe therapies while securing intellectual property through numerous granted patents.

Immune Targeting Systems (ITS) Limited specializes in the development of synthetic vaccines aimed at combating mutating viruses. The company utilizes a T-cell vaccine platform that targets highly conserved viral antigens, directing the immune response specifically to infected cells. This innovative approach employs fluoropeptide vaccine technology, allowing for robust T-cell immunity without the need for potentially harmful adjuvants typically used to enhance vaccine efficacy. Founded in late 2003 and based in the London BioScience Innovation Centre, ITS has focused its efforts on creating vaccines for various viral infections, including seasonal and pandemic influenza, as well as life-threatening conditions such as HIV/AIDS and hepatitis. The company gained significant financial backing in 2007 from a group of investors, which included the Novartis Venture Fund and HealthCap, alongside support from the London Development Agency.

Symetis is a Swiss company based in Ecublens that specializes in developing innovative minimally invasive heart valve replacement therapies. The company focuses on improving patient care and safety through its proprietary Acurate™ Aortic Valve Replacement System, which features a unique self-positioning design. This design allows for easier implant positioning and alignment, enhancing the overall user experience for healthcare providers. Symetis aims to address the needs of patients suffering from aortic valve stenosis, enabling the effective treatment of severe cardiac valve conditions through its advanced transcatheter aortic valve implantation devices.

Eco-Carbone provides consulting and project development services in the area of climate change mitigation.

CARMAT is a France-based medtech company that specializes in the development and manufacture of bioprosthetic artificial hearts aimed at treating patients with severe heart failure. Founded in 2008 and located in Vélizy-Villacoublay, the company produces biocompatible and auto-regulated total artificial hearts that closely mimic the human heart's functionality. These devices are designed for individuals experiencing chronic terminal heart failure classified as NYHA class IV or those suffering from acute terminal heart failure following a major heart attack. CARMAT's innovative solutions target patients who are not suitable for heart transplantation and have exhausted other treatment options, providing a reliable new therapeutic alternative. In addition to the artificial hearts, CARMAT also develops the associated power supply and control systems, including remote diagnosis capabilities.

OSEAD Maroc Mining operates as a metal and mining platform. OSEAD is a holding company specialising in the prospecting, exploration and mining of mineral deposits. OSEAD’s main asset is Compagnie Minière de Touissit the second largest private mining operator in Morocco, which mines primarily lead and silver with some zinc.

PeopleCube is a provider of intelligent on-demand workplace management solutions headquartered in Framingham, Massachusetts, with additional offices worldwide. The company offers a suite of software designed for scheduling and facility management, enabling organizations to optimize their workspace usage and reduce costs associated with real estate, meeting services, travel, and energy. Among its offerings are resource scheduling software, which facilitates the management of alternative workspaces, room bookings, video conferencing, and visitor and event management. With a customer base of approximately 7,500 organizations across various sectors, PeopleCube aims to enhance operational efficiency through its data-driven approach to workplace management.

Neovacs is a biotechnology company founded in 1993 as a spin-off from the Pierre & Marie Curie University in Paris by Professor Daniel Zagury, a prominent immunologist. The company specializes in the development of therapeutic vaccines known as "Kinoids," which are designed to treat a range of conditions including autoimmune diseases, allergies, and cancer. Neovacs holds an extensive patent portfolio and is recognized for its innovative approach to vaccine development, particularly in creating vaccines that target human cytokines and immunosuppressive viral proteins. Unlike traditional monoclonal antibody treatments that provide exogenous therapies, Neovacs' therapeutic vaccines promote a robust natural polyclonal antibody response in patients, positioning the company as a pioneer in the field of immunotherapy.

Immune Targeting Systems (ITS) Limited specializes in the development of synthetic vaccines aimed at combating mutating viruses. The company utilizes a T-cell vaccine platform that targets highly conserved viral antigens, directing the immune response specifically to infected cells. This innovative approach employs fluoropeptide vaccine technology, allowing for robust T-cell immunity without the need for potentially harmful adjuvants typically used to enhance vaccine efficacy. Founded in late 2003 and based in the London BioScience Innovation Centre, ITS has focused its efforts on creating vaccines for various viral infections, including seasonal and pandemic influenza, as well as life-threatening conditions such as HIV/AIDS and hepatitis. The company gained significant financial backing in 2007 from a group of investors, which included the Novartis Venture Fund and HealthCap, alongside support from the London Development Agency.

Cytomics Systems is a French private company that offers bio-pharmacology services. The company uses Yeast Micro-Lab technology, a protenomics tool, which enables to follow in-vitro deterioration of proteins. Cytomics Systems's research and development focuses on fungicidal infections, inflammatory illnesses, and cancers. Cytomics Systems, S.A was founded in 2000 and is based in Gif-sur-Yvette, France.

RF-iT Solutions GmbH specializes in radio frequency identification (RFID) software solutions and services. Founded in 2005 and headquartered in Graz, Austria, the company develops a range of products, including You-R® OPEN, an RFID operating environment designed for system integrators and software manufacturers. The company’s offerings include You-R Smart Fashion, a supply chain solution for the textile and apparel industry, You-R® DOCUTRACER, a web-based application for data storage aimed at patent lawyers and hospitals, You-R® PHARMA for pharmaceutical packaging, You-R® RETAIL for inventory management, You-R® SECURE for brand protection, and You-R® VIRTUAL TUNNEL for tracking product allocation. Additionally, RF-iT Solutions provides RFID middleware and consulting services, including business case analysis and feasibility studies. Its diverse client base spans various industries, such as fashion, automotive, industrial manufacturing, pharmaceuticals, retail, consumer packaged goods, logistics, asset management, and healthcare. The company also has locations in Germany, France, and the United Kingdom.

Deinove SA is a biotechnology company based in Grabels, France, focused on discovering, developing, and producing microbial-derived compounds for the health, nutrition, and cosmetics sectors. The company is advancing its portfolio of antibiotic candidates, including DNV3837, which is currently undergoing Phase II clinical trials for treating Clostridioides difficile infections. In the cosmetics arena, Deinove offers various bioactive ingredients such as PHYT-N-Resist, Luminity, HEBELYS, and BIOME Oléoactif, which serve functions ranging from anti-aging to balancing skin microbiota. Additionally, Deinove is exploring processes for producing natural ingredients for animal feed. The company has established partnerships with several organizations, including bioMérieux and the Institut Pasteur, to enhance its research and development initiatives. Founded in 2006, Deinove is committed to leveraging its bacterial biodiversity to create sustainable solutions across multiple industries.

TheraDiag is a France-based company specializing in the development, manufacturing, and marketing of in-vitro diagnostic products. Founded in 1986 and headquartered in Marne La Vallée, the company offers a range of diagnostic tools, including reagents for autoimmune and infectious diseases, as well as fertility tests. Notable products include IMMUNO-TROL, a quality control tool; various instruments for disease testing; and the SQA-V semen analyzer. TheraDiag also provides advanced instrumentation such as the Theralis platform, which integrates immunofluorescence and ELISA technologies, and the FIDIS platform for laboratory analysis. Additionally, the company offers therapeutic drug monitoring services for chronic inflammatory diseases and LISA tracker, a tool designed for monitoring biotherapies.

AS Group is a Parisian company and a spin-off of Deloitte, was a corporate performance software vendor.

EquiTime specializes in workforce management solutions that enable organizations to effectively create, track, and analyze employee schedules while accommodating the unique requirements of various professions. The company enhances traditional time and activity management by incorporating forecasting capabilities, which not only boosts productivity but also fosters better relationships between employees and customers. Through its product, AgileTime, EquiTime provides comprehensive human resources management software along with services such as training, integration with HR information systems, tailored developments, and functional support. This approach aims to streamline human resource processes and improve overall operational efficiency.

TheraDiag is a France-based company specializing in the development, manufacturing, and marketing of in-vitro diagnostic products. Founded in 1986 and headquartered in Marne La Vallée, the company offers a range of diagnostic tools, including reagents for autoimmune and infectious diseases, as well as fertility tests. Notable products include IMMUNO-TROL, a quality control tool; various instruments for disease testing; and the SQA-V semen analyzer. TheraDiag also provides advanced instrumentation such as the Theralis platform, which integrates immunofluorescence and ELISA technologies, and the FIDIS platform for laboratory analysis. Additionally, the company offers therapeutic drug monitoring services for chronic inflammatory diseases and LISA tracker, a tool designed for monitoring biotherapies.